MedPath

MAYO CLINIC

MAYO CLINIC logo
🇺🇸United States
Ownership
Subsidiary
Established
1889-01-01
Employees
10K
Market Cap
-
Website
http://www.mayoclinic.org

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease

Phase 4
Completed
Conditions
Inflammatory Bowel Disease
Uterine Cervical Dysplasia
Interventions
Biological: Human Papillomavirus Vaccine
First Posted Date
2009-12-17
Last Posted Date
2012-10-23
Lead Sponsor
Mayo Clinic
Target Recruit Count
15
Registration Number
NCT01034358
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1
Completed
Conditions
Refractory Multiple Myeloma
Interventions
Drug: Aurora A kinase inhibitor MLN8237
Drug: bortezomib
First Posted Date
2009-12-17
Last Posted Date
2016-05-25
Lead Sponsor
Mayo Clinic
Target Recruit Count
26
Registration Number
NCT01034553
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

🇺🇸

Dana-Farber Cancer Institute, Boston, Massachusetts, United States

🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

and more 3 locations

Alveoscopy, Endoscopic Confocal Microscopy and Lung Rejection, Parenchymal Lung Diseases in Vivo

Completed
Conditions
Lung Transplant
Interventions
Other: Confocal imaging
First Posted Date
2009-12-16
Last Posted Date
2012-01-26
Lead Sponsor
Mayo Clinic
Target Recruit Count
71
Registration Number
NCT01033201
Locations
🇺🇸

Mayo Clinic Florida, Jacksonville, Florida, United States

A Trial Comparing Yield of Confocal Endomicroscopy Guided Biopsies

Phase 4
Terminated
Conditions
Barrett's Esophagus
Interventions
Other: Fluorescence-aided confocal endomicroscopy guided biopsy.
Other: Random four-quadrant biopsies.
First Posted Date
2009-12-11
Last Posted Date
2010-03-25
Lead Sponsor
Mayo Clinic
Target Recruit Count
18
Registration Number
NCT01030263
Locations
🇺🇸

Mayo Clinic, Scottsdale, Arizona, United States

Effect of Surgery and Radiation Therapy on Tc-99M Sestamibi Uptake Patterns in Molecular Breast Imaging

Completed
Conditions
Breast Cancer
Interventions
Device: Molecular Breast Imaging
First Posted Date
2009-12-09
Last Posted Date
2013-02-15
Lead Sponsor
Mayo Clinic
Target Recruit Count
23
Registration Number
NCT01027767
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

Impact of Decision Aids to Enhance Shared Decision Making for Diabetes

Not Applicable
Completed
Conditions
Diabetes
Interventions
Other: Diabetes Medication Choice Decision Aid
Other: Statin Choice Decision Aid
Other: Usual care for lipid therapy medication
Other: Usual care for antihyperglycemic medication
First Posted Date
2009-12-09
Last Posted Date
2016-02-02
Lead Sponsor
Mayo Clinic
Target Recruit Count
110
Registration Number
NCT01029288
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

🇺🇸

Olmsted Medical Center, Rochester, Minnesota, United States

🇺🇸

MCHS-Austin, Austin, Minnesota, United States

and more 2 locations

The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With Breast Cancer

Completed
Conditions
Neoadjuvant Therapy
Chemotherapy
Hormone Replacement Therapy
Breast Cancer
First Posted Date
2009-12-02
Last Posted Date
2013-05-10
Lead Sponsor
Mayo Clinic
Target Recruit Count
20
Registration Number
NCT01023802
Locations
🇺🇸

Mayo Clinic - Rochester, Rochester, Minnesota, United States

Study to Evaluate the Diagnostic Value of a Combined Molecular Breast Imaging/ Breast Tomosynthesis Modality

Withdrawn
Conditions
Breast Cancer
First Posted Date
2009-12-02
Last Posted Date
2012-04-18
Lead Sponsor
Mayo Clinic
Registration Number
NCT01024114
Locations
🇺🇸

Mayo Clinic - Rochester, Rochester, Minnesota, United States

Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 2
Completed
Conditions
Stage I Small Lymphocytic Lymphoma
Stage II Chronic Lymphocytic Leukemia
Stage III Small Lymphocytic Lymphoma
Stage IV Chronic Lymphocytic Leukemia
Stage 0 Chronic Lymphocytic Leukemia
Stage I Chronic Lymphocytic Leukemia
Stage II Small Lymphocytic Lymphoma
Stage III Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
Stage IV Small Lymphocytic Lymphoma
Interventions
Drug: Cyclophosphamide
Other: Laboratory Biomarker Analysis
Biological: Ofatumumab
Drug: Pentostatin
First Posted Date
2009-12-02
Last Posted Date
2018-09-18
Lead Sponsor
Mayo Clinic
Target Recruit Count
82
Registration Number
NCT01024010
Locations
🇺🇸

Mayo Clinic in Arizona, Scottsdale, Arizona, United States

🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

and more 1 locations

"Pilot Study of Armodafinil in Patients With Dementia With Lewy Bodies"

Phase 4
Completed
Conditions
Dementia With Lewy Bodies
Interventions
First Posted Date
2009-12-02
Last Posted Date
2013-09-05
Lead Sponsor
Mayo Clinic
Target Recruit Count
20
Registration Number
NCT01023672
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath